<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.0 20040830//EN" "http://dtd.nlm.nih.gov/publishing/2.0/journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="letter" dtd-version="2.0">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">JDERM</journal-id>
      <journal-id journal-id-type="nlm-ta">JMIR Dermatol</journal-id>
      <journal-title>JMIR Dermatology</journal-title>
      <issn pub-type="epub">2562-0959</issn>
      <publisher>
        <publisher-name>JMIR Publications</publisher-name>
        <publisher-loc>Toronto, Canada</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">v6i1e48140</article-id>
      <article-id pub-id-type="pmid">37624704</article-id>
      <article-id pub-id-type="doi">10.2196/48140</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Letter</subject>
        </subj-group>
        <subj-group subj-group-type="article-type">
          <subject>Research Letter</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Short-Form Medical Media: A Multi-Platform Analysis of Acne Treatment Information in TikTok Videos, Instagram Reels, and YouTube Shorts</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="editor">
          <name>
            <surname>Dellavalle</surname>
            <given-names>Robert</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="reviewer">
          <name>
            <surname>Szeto</surname>
            <given-names>Mindy</given-names>
          </name>
        </contrib>
        <contrib contrib-type="reviewer">
          <name>
            <surname>Long</surname>
            <given-names>Valencia</given-names>
          </name>
        </contrib>
        <contrib contrib-type="reviewer">
          <name>
            <surname>Roster</surname>
            <given-names>Katie</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib id="contrib1" contrib-type="author">
          <name name-style="western">
            <surname>Thang</surname>
            <given-names>Christopher J</given-names>
          </name>
          <degrees>BS</degrees>
          <xref rid="aff1" ref-type="aff">1</xref>
          <ext-link ext-link-type="orcid">https://orcid.org/0000-0002-2951-6225</ext-link>
        </contrib>
        <contrib id="contrib2" contrib-type="author">
          <name name-style="western">
            <surname>Garate</surname>
            <given-names>David</given-names>
          </name>
          <degrees>BS</degrees>
          <xref rid="aff1" ref-type="aff">1</xref>
          <ext-link ext-link-type="orcid">https://orcid.org/0000-0003-3622-755X</ext-link>
        </contrib>
        <contrib id="contrib3" contrib-type="author">
          <name name-style="western">
            <surname>Thang</surname>
            <given-names>Joseph</given-names>
          </name>
          <xref rid="aff2" ref-type="aff">2</xref>
          <ext-link ext-link-type="orcid">https://orcid.org/0009-0001-3738-8278</ext-link>
        </contrib>
        <contrib id="contrib4" contrib-type="author">
          <name name-style="western">
            <surname>Lipoff</surname>
            <given-names>Jules B</given-names>
          </name>
          <degrees>MD</degrees>
          <xref rid="aff3" ref-type="aff">3</xref>
          <ext-link ext-link-type="orcid">https://orcid.org/0000-0002-0557-4260</ext-link>
        </contrib>
        <contrib id="contrib5" contrib-type="author" corresp="yes">
          <name name-style="western">
            <surname>Barbieri</surname>
            <given-names>John S</given-names>
          </name>
          <degrees>MBA, MD</degrees>
          <xref rid="aff4" ref-type="aff">4</xref>
          <address>
            <institution>Department of Dermatology</institution>
            <institution>Brigham and Women’s Hospital</institution>
            <addr-line>221 Longwood Ave</addr-line>
            <addr-line>Boston, MA, 02115</addr-line>
            <country>United States</country>
            <phone>1 617 732 4918</phone>
            <email>jbarbieri@bwh.harvard.edu</email>
          </address>
          <ext-link ext-link-type="orcid">https://orcid.org/0000-0002-5467-4102</ext-link>
        </contrib>
      </contrib-group>
      <aff id="aff1">
        <label>1</label>
        <institution>John Sealy School of Medicine</institution>
        <institution>University of Texas Medical Branch</institution>
        <addr-line>Galveston, TX</addr-line>
        <country>United States</country>
      </aff>
      <aff id="aff2">
        <label>2</label>
        <institution>Texas A&#38;M University</institution>
        <addr-line>College Station, TX</addr-line>
        <country>United States</country>
      </aff>
      <aff id="aff3">
        <label>3</label>
        <institution>Department of Dermatology</institution>
        <institution>Lewis Katz School of Medicine at Temple University</institution>
        <addr-line>Philadelphia, PA</addr-line>
        <country>United States</country>
      </aff>
      <aff id="aff4">
        <label>4</label>
        <institution>Department of Dermatology</institution>
        <institution>Brigham and Women’s Hospital</institution>
        <addr-line>Boston, MA</addr-line>
        <country>United States</country>
      </aff>
      <author-notes>
        <corresp>Corresponding Author: John S Barbieri <email>jbarbieri@bwh.harvard.edu</email></corresp>
      </author-notes>
      <pub-date pub-type="collection">
        <year>2023</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>9</day>
        <month>8</month>
        <year>2023</year>
      </pub-date>
      <volume>6</volume>
      <elocation-id>e48140</elocation-id>
      <history>
        <date date-type="received">
          <day>12</day>
          <month>4</month>
          <year>2023</year>
        </date>
        <date date-type="rev-request">
          <day>15</day>
          <month>6</month>
          <year>2023</year>
        </date>
        <date date-type="rev-recd">
          <day>7</day>
          <month>7</month>
          <year>2023</year>
        </date>
        <date date-type="accepted">
          <day>25</day>
          <month>7</month>
          <year>2023</year>
        </date>
      </history>
      <copyright-statement>©Christopher J Thang, David Garate, Joseph Thang, Jules B Lipoff, John S Barbieri. Originally published in JMIR Dermatology (http://derma.jmir.org), 09.08.2023.</copyright-statement>
      <copyright-year>2023</copyright-year>
      <license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/">
        <p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Dermatology, is properly cited. The complete bibliographic information, a link to the original publication on http://derma.jmir.org, as well as this copyright and license information must be included.</p>
      </license>
      <self-uri xlink:href="https://derma.jmir.org/2023/1/e48140" xlink:type="simple"/>
      <kwd-group>
        <kwd>general dermatology</kwd>
        <kwd>medical dermatology</kwd>
        <kwd>acne</kwd>
        <kwd>acne treatment</kwd>
        <kwd>social media</kwd>
        <kwd>TikTok</kwd>
        <kwd>Instagram Reels</kwd>
        <kwd>YouTube Shorts</kwd>
        <kwd>YouTube</kwd>
        <kwd>Instagram</kwd>
        <kwd>video</kwd>
        <kwd>dermatology</kwd>
        <kwd>skin</kwd>
        <kwd>patient education</kwd>
        <kwd>health information</kwd>
        <kwd>online information</kwd>
        <kwd>dermatologist</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="introduction">
      <title>Introduction</title>
      <p>Social media has emerged as a medium for dermatologists to disseminate educational content [<xref ref-type="bibr" rid="ref1">1</xref>-<xref ref-type="bibr" rid="ref3">3</xref>]. Adolescents extensively use social media as a resource [<xref ref-type="bibr" rid="ref1">1</xref>], with 75% of adolescent patients with acne reporting they consult social media for treatment information [<xref ref-type="bibr" rid="ref4">4</xref>]. However, many dermatologic posts are low in educational quality, especially those made by non–board-certified dermatologists [<xref ref-type="bibr" rid="ref2">2</xref>]. TikTok has emerged as a wide-reaching, short-form video platform used by millions of adolescents and adults worldwide [<xref ref-type="bibr" rid="ref1">1</xref>,<xref ref-type="bibr" rid="ref3">3</xref>]. The short-form video structure has since been emulated in Instagram Reels (IGR) and YouTube Shorts (YTS). However, little is known about how the quality of acne treatment content varies across these platforms and how they compare to each other.</p>
    </sec>
    <sec sec-type="methods">
      <title>Methods</title>
      <p>To assess the content and educational quality of videos on acne treatment across TikTok, IGR, and YTS, we acquired the top 300 videos per platform from TikTok (search: “acne treatment”), IGR (search: “#acnetreatment”), and YTS (search: “#shorts + acne treatment”) on March 9, 2023. Videos were excluded if they were irrelevant to acne treatment, noneducational, duplicate content, not in English, or made unavailable, as well as if they had hidden metrics or the treatment was unspecified. Video metrics and video engagement rate (VER) ([likes + comments per post]/[followers] × 100] were determined [<xref ref-type="bibr" rid="ref3">3</xref>]. Video creators were stratified by creator type through review of their profile (dermatologist/dermatology practice, nondermatologist physician/medical clinic, layperson, influencer, or other). “Influencer” was defined as a layperson with at least 40,000 followers [<xref ref-type="bibr" rid="ref3">3</xref>]. “Other” was categorized as having a specific profession or niche related to skin health (eg, skincare company, aesthetician). Two independent reviewers rated videos using the DISCERN Instrument, which allows health care providers to evaluate the quality of consumer health information, and the Global Quality Scale (GQS), which scores each video based on clinical usefulness [<xref ref-type="bibr" rid="ref5">5</xref>]. Any discrepancies were handled by consensus. Following video exclusion, a multiple regression analysis was performed to evaluate the association between the platform (ie, TikTok, IGR, and YTS) and creator type with DISCERN and GQS scores, controlling for upload date.</p>
    </sec>
    <sec sec-type="results">
      <title>Results</title>
      <p>Of the videos analyzed, 32.8% (82/250) were created by dermatologists/dermatology practices, 5.60% (14/250) were by nondermatologist physicians/medical clinics, 27.2% (68/250) were by laypersons, 20.8% (52/250) were by influencers, and 13.6% (34/250) were by others. The average number of views per video was 1,639,969 on TikTok, 689,897 on YTS, and 27,192 on IGR. DISCERN and GQS scores were significantly higher for dermatologists than any other creator type across all platforms (<xref ref-type="table" rid="table1">Table 1</xref>). Posts from laypersons had a significantly higher VER compared to posts from dermatologists (<xref ref-type="table" rid="table1">Table 1</xref>). The most common therapies discussed were benzoyl peroxide, salicylic acid, adapalene, and preventative measures. IGR had a higher rate of discussion of complementary and alternative therapies compared to other platforms (<xref ref-type="table" rid="table2">Table 2</xref>).</p>
      <p><xref ref-type="table" rid="table2">Table 2</xref> presents the number of treatment recommendations among those videos. Topical prescription medications included retinoids, antibiotics, antiandrogens, and steroids. Oral hormonal therapy included birth control pills and spironolactone. Procedural treatments included lasers or lights, chemical peels, extraction, and corticosteroid injections. Complementary and alternative therapies included treatments and suggestions that did not fall into any other category and were nonpreventative measures. Preventative measures included optimizing diet, avoiding pore-clogging makeup, managing stress, exercising, and avoiding picking at pimples.</p>
      <table-wrap position="float" id="table1">
        <label>Table 1</label>
        <caption>
          <p>Analysis of the DISCERN score, the Global Quality Scale (GQS) score, and the video engagement rate (VER).</p>
        </caption>
        <table width="1000" cellpadding="5" cellspacing="0" border="1" rules="groups" frame="hsides">
          <col width="30"/>
          <col width="180"/>
          <col width="70"/>
          <col width="110"/>
          <col width="70"/>
          <col width="0"/>
          <col width="70"/>
          <col width="110"/>
          <col width="70"/>
          <col width="0"/>
          <col width="110"/>
          <col width="110"/>
          <col width="70"/>
          <thead>
            <tr valign="top">
              <td colspan="2">
                <break/>
              </td>
              <td colspan="4">DISCERN</td>
              <td colspan="4">GQS</td>
              <td colspan="3">VER</td>
            </tr>
            <tr valign="top">
              <td colspan="2"> </td>
              <td>Score, mean</td>
              <td>Coefficient (95% CI)</td>
              <td><italic>P</italic> value<sup>a</sup></td>
              <td colspan="2">Score, mean</td>
              <td>Coefficient (95% CI)</td>
              <td><italic>P</italic> value</td>
              <td colspan="2">Rate (%), mean</td>
              <td>Coefficient (95% CI)</td>
              <td><italic>P</italic> value</td>
            </tr>
          </thead>
          <tbody>
            <tr valign="top">
              <td colspan="2">
                <bold>Platform</bold>
              </td>
              <td> </td>
              <td> </td>
              <td>
                <break/>
              </td>
              <td colspan="2"> </td>
              <td> </td>
              <td>
                <break/>
              </td>
              <td colspan="2"> </td>
              <td> </td>
              <td>
                <break/>
              </td>
            </tr>
            <tr valign="top">
              <td>
                <break/>
              </td>
              <td>Instagram Reels (n=64)</td>
              <td>36.9</td>
              <td>Ref<sup>b</sup></td>
              <td>
                <break/>
              </td>
              <td colspan="2">2.70</td>
              <td>Ref</td>
              <td>
                <break/>
              </td>
              <td colspan="2">4.3</td>
              <td>Ref</td>
              <td>
                <break/>
              </td>
            </tr>
            <tr valign="top">
              <td>
                <break/>
              </td>
              <td>TikTok (n=112)</td>
              <td>40.8</td>
              <td>1.99 (–0.19 to 4.17)</td>
              <td>.07</td>
              <td colspan="2">2.94</td>
              <td>–0.03 (–0.26 to 0.21)</td>
              <td>.83</td>
              <td colspan="2">689.4</td>
              <td>1025.87 (479 to 1572.75)</td>
              <td>
                <italic>&#60;.001</italic>
              </td>
            </tr>
            <tr valign="top">
              <td>
                <break/>
              </td>
              <td>YouTube Shorts (n=74)</td>
              <td>42.4</td>
              <td>1.49 (–1.27 to 4.25)</td>
              <td>.29</td>
              <td colspan="2">3.26</td>
              <td>0 (–0.3 to 0.3)</td>
              <td>.98</td>
              <td colspan="2">62.4</td>
              <td>492.64 (–199.73 to 1185)</td>
              <td>.16</td>
            </tr>
            <tr valign="top">
              <td colspan="2">
                <bold>Creator type</bold>
              </td>
              <td> </td>
              <td> </td>
              <td>
                <break/>
              </td>
              <td colspan="2"> </td>
              <td> </td>
              <td>
                <break/>
              </td>
              <td colspan="2"> </td>
              <td> </td>
              <td>
                <break/>
              </td>
            </tr>
            <tr valign="top">
              <td>
                <break/>
              </td>
              <td>Dermatologist/dermatology clinic (n=82)</td>
              <td>46.1</td>
              <td>Ref</td>
              <td>
                <break/>
              </td>
              <td colspan="2">3.88</td>
              <td>Ref</td>
              <td>
                <break/>
              </td>
              <td colspan="2">80.7</td>
              <td>Ref</td>
              <td>
                <break/>
              </td>
            </tr>
            <tr valign="top">
              <td>
                <break/>
              </td>
              <td>Nondermatologist physician/medical clinic (n=14)</td>
              <td>41.6</td>
              <td>–4.41 (–8.09 to –0.73)</td>
              <td>
                <italic>.02</italic>
              </td>
              <td colspan="2">3.00</td>
              <td>–0.88 (–1.28 to –0.49)</td>
              <td>
                <italic>&#60;.001</italic>
              </td>
              <td colspan="2">86.8</td>
              <td>149.1 (–774.82 to 1073.01)</td>
              <td>.75</td>
            </tr>
            <tr valign="top">
              <td>
                <break/>
              </td>
              <td>Layperson (n=68)</td>
              <td>36.3</td>
              <td>–9 (–11.19 to –6.81)</td>
              <td>
                <italic>&#60;.001</italic>
              </td>
              <td colspan="2">2.41</td>
              <td>–1.46 (–1.7 to –1.22)</td>
              <td>
                <italic>&#60;.001</italic>
              </td>
              <td colspan="2">973</td>
              <td>1069.21 (519.91 to 1618.51)</td>
              <td>
                <italic>&#60;.001</italic>
              </td>
            </tr>
            <tr valign="top">
              <td>
                <break/>
              </td>
              <td>Influencer (n=52)</td>
              <td>37.5</td>
              <td>–8.25 (–10.53 to –5.96)</td>
              <td>
                <italic>&#60;.001</italic>
              </td>
              <td colspan="2">2.60</td>
              <td>–1.27 (–1.52 to –1.02)</td>
              <td>
                <italic>&#60;.001</italic>
              </td>
              <td colspan="2">70.3</td>
              <td>–47.59 (–621.53 to 526.35)</td>
              <td>.87</td>
            </tr>
            <tr valign="top">
              <td>
                <break/>
              </td>
              <td>Other (n=34)</td>
              <td>38.1</td>
              <td>–7.67 (–10.28 to –5.06)</td>
              <td>
                <italic>&#60;.001</italic>
              </td>
              <td colspan="2">2.50</td>
              <td>–1.37 (–1.65 to –1.08)</td>
              <td>
                <italic>&#60;.001</italic>
              </td>
              <td colspan="2">131</td>
              <td>11.22 (–644.61 to 667.06)</td>
              <td>.97</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn id="table1fn1">
            <p><sup>a</sup>Italicized values are significant.</p>
          </fn>
          <fn id="table1fn2">
            <p><sup>b</sup>Ref: reference.</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
      <table-wrap position="float" id="table2">
        <label>Table 2</label>
        <caption>
          <p>Acne treatments specified across platforms TikTok, Instagram Reels, and YouTube Shorts and creator types.</p>
        </caption>
        <table width="1000" cellpadding="5" cellspacing="0" border="1" rules="groups" frame="hsides">
          <col width="130"/>
          <col width="170"/>
          <col width="120"/>
          <col width="0"/>
          <col width="170"/>
          <col width="120"/>
          <col width="0"/>
          <col width="170"/>
          <col width="120"/>
          <thead>
            <tr valign="top">
              <td>
                <break/>
              </td>
              <td colspan="3">TikTok</td>
              <td colspan="3">Instagram Reels</td>
              <td colspan="2">YouTube Shorts</td>
            </tr>
            <tr valign="top">
              <td>
                <break/>
              </td>
              <td>Dermatologist/dermatology practice (n=36)</td>
              <td>Nondermatologist (n=76)</td>
              <td colspan="2">Dermatologist/dermatology practice (n=10)</td>
              <td>Nondermatologist (n=54)</td>
              <td colspan="2">Dermatologist/dermatology practice (n=36)</td>
              <td>Nondermatologist (n=38)</td>
            </tr>
          </thead>
          <tbody>
            <tr valign="top">
              <td>Treatments mentioned, N</td>
              <td>97</td>
              <td>176</td>
              <td colspan="2">16</td>
              <td>84</td>
              <td colspan="2">109</td>
              <td>67</td>
            </tr>
            <tr valign="top">
              <td>Benzoyl peroxide, n (%)</td>
              <td>18 (19)</td>
              <td>22 (13)</td>
              <td colspan="2">2 (13)</td>
              <td>3 (4)</td>
              <td colspan="2">20 (18)</td>
              <td>8 (12)</td>
            </tr>
            <tr valign="top">
              <td>Salicylic acid, n (%)</td>
              <td>15 (15)</td>
              <td>26 (15)</td>
              <td colspan="2">1 (6)</td>
              <td>24 (29)</td>
              <td colspan="2">17 (16)</td>
              <td>12 (18)</td>
            </tr>
            <tr valign="top">
              <td>Other topical OTC<sup>a</sup> treatments, n (%)</td>
              <td>21 (22)</td>
              <td>53 (30)</td>
              <td colspan="2">4 (25)</td>
              <td>41 (49)</td>
              <td colspan="2">19 (17)</td>
              <td>24 (36)</td>
            </tr>
            <tr valign="top">
              <td>Adapalene (OTC), n (%)</td>
              <td>17 (18)</td>
              <td>8 (5)</td>
              <td colspan="2">2 (13)</td>
              <td>0 (0)</td>
              <td colspan="2">14 (13)</td>
              <td>1 (1)</td>
            </tr>
            <tr valign="top">
              <td>Topical prescription medications, n (%)</td>
              <td>6 (6)</td>
              <td>24 (14)</td>
              <td colspan="2">2 (13)</td>
              <td>1 (1)</td>
              <td colspan="2">12 (11)</td>
              <td>3 (4)</td>
            </tr>
            <tr valign="top">
              <td>Oral antibiotics, n (%)</td>
              <td>1 (1)</td>
              <td>2 (1)</td>
              <td colspan="2">0 (0)</td>
              <td>0 (0)</td>
              <td colspan="2">3 (3)</td>
              <td>3 (4)</td>
            </tr>
            <tr valign="top">
              <td>Oral hormonal therapy, n (%)</td>
              <td>3 (3)</td>
              <td>6 (3)</td>
              <td colspan="2">1 (6)</td>
              <td>0 (0)</td>
              <td colspan="2">5 (5)</td>
              <td>1 (1)</td>
            </tr>
            <tr valign="top">
              <td>Isotretinoin, n (%)</td>
              <td>7 (7)</td>
              <td>5 (3)</td>
              <td colspan="2">0 (0)</td>
              <td>0 (0)</td>
              <td colspan="2">6 (6)</td>
              <td>1 (1)</td>
            </tr>
            <tr valign="top">
              <td>Procedural treatments, n (%)</td>
              <td>1 (1)</td>
              <td>7 (4)</td>
              <td colspan="2">0 (0)</td>
              <td>5 (6)</td>
              <td colspan="2">5 (5)</td>
              <td>6 (9)</td>
            </tr>
            <tr valign="top">
              <td>Complementary and alternative therapies, n (%)</td>
              <td>0 (0)</td>
              <td>8 (5)</td>
              <td colspan="2">3 (19)</td>
              <td>6 (7)</td>
              <td colspan="2">0 (0)</td>
              <td>2 (3)</td>
            </tr>
            <tr valign="top">
              <td>Preventative measures, n (%)</td>
              <td>8 (8)</td>
              <td>15 (9)</td>
              <td colspan="2">1 (6)</td>
              <td>4 (5)</td>
              <td colspan="2">8 (7)</td>
              <td>6 (9)</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn id="table2fn1">
            <p><sup>a</sup>OTC: over the counter.</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
    </sec>
    <sec sec-type="discussion">
      <title>Discussion</title>
      <p>Our study demonstrates that short-form social media platforms predominantly feature dermatology content created by nondermatologists; however, content produced by board-certified dermatologists was of significantly higher quality as evaluated by the DISCERN and GQS scores. Given the popularity of social media among adolescents with acne [<xref ref-type="bibr" rid="ref1">1</xref>,<xref ref-type="bibr" rid="ref4">4</xref>], there is an opportunity for more dermatologists to create content in these spaces where patients seek information. Although the rigorous outcome assessment with DISCERN and GQS scores is a strength of this study, given the rapidly evolving nature of social media, it will be important to reassess these findings over time.</p>
      <p>Overall, content on these platforms heavily skewed toward over-the-counter (OTC) treatments, which may reflect the types of treatments that those with acne seek out on social media. However, for many with acne, OTC treatments will be insufficient and prescription therapy will be required. Consequently, dermatologists may find an opportunity on social media to better educate the community regarding prescription acne treatments and to correct misconceptions regarding how to approach OTC management of acne. </p>
    </sec>
  </body>
  <back>
    <app-group/>
    <glossary>
      <title>Abbreviations</title>
      <def-list>
        <def-item>
          <term id="abb1">GQS</term>
          <def>
            <p>Global Quality Scale</p>
          </def>
        </def-item>
        <def-item>
          <term id="abb2">IGR</term>
          <def>
            <p>Instagram Reels</p>
          </def>
        </def-item>
        <def-item>
          <term id="abb3">OTC</term>
          <def>
            <p>over the counter</p>
          </def>
        </def-item>
        <def-item>
          <term id="abb4">VER</term>
          <def>
            <p>video engagement rate</p>
          </def>
        </def-item>
        <def-item>
          <term id="abb5">YTS</term>
          <def>
            <p>YouTube Shorts</p>
          </def>
        </def-item>
      </def-list>
    </glossary>
    <ack>
      <p>JSB is supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health under award number 1K23AR078930. </p>
    </ack>
    <fn-group>
      <fn fn-type="con">
        <p>CJT created the study. CJT and DG scored the videos in the study. JT acquired all study videos and video metrics. JSB performed the statistical analysis and supervised the study design and implementation. JBL assisted in data interpretation and table design. CJT, DG, JBL, and JSB drafted the manuscript.</p>
      </fn>
      <fn fn-type="conflict">
        <p>JSB has received consulting fees from Dexcel Pharma for work unrelated to the current submission. JBL is an editorial board member of <italic>JMIR Dermatology</italic>. The authors have no other conflicts to declare.</p>
      </fn>
    </fn-group>
    <ref-list>
      <ref id="ref1">
        <label>1</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Roche</surname>
              <given-names>L</given-names>
            </name>
            <name name-style="western">
              <surname>Nic Dhonncha</surname>
              <given-names>E</given-names>
            </name>
            <name name-style="western">
              <surname>Murphy</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>TikTok™ and dermatology: promises and pearls</article-title>
          <source>Clin Exp Dermatol</source>
          <year>2021</year>
          <month>07</month>
          <day>31</day>
          <volume>46</volume>
          <issue>4</issue>
          <fpage>737</fpage>
          <lpage>739</lpage>
          <pub-id pub-id-type="doi">10.1111/ced.14529</pub-id>
          <pub-id pub-id-type="medline">33258146</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref2">
        <label>2</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Guzman</surname>
              <given-names>AK</given-names>
            </name>
            <name name-style="western">
              <surname>Wang</surname>
              <given-names>RH</given-names>
            </name>
            <name name-style="western">
              <surname>Nazarian</surname>
              <given-names>RS</given-names>
            </name>
            <name name-style="western">
              <surname>Barbieri</surname>
              <given-names>JS</given-names>
            </name>
          </person-group>
          <article-title>Evaluation of YouTube as an educational resource for treatment options of common dermatologic conditions</article-title>
          <source>Int J Dermatol</source>
          <year>2020</year>
          <month>03</month>
          <day>20</day>
          <volume>59</volume>
          <issue>3</issue>
          <fpage>e65</fpage>
          <lpage>e67</lpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://europepmc.org/abstract/MED/31631334"/>
          </comment>
          <pub-id pub-id-type="doi">10.1111/ijd.14693</pub-id>
          <pub-id pub-id-type="medline">31631334</pub-id>
          <pub-id pub-id-type="pmcid">PMC7007825</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref3">
        <label>3</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Szeto</surname>
              <given-names>MD</given-names>
            </name>
            <name name-style="western">
              <surname>Presley</surname>
              <given-names>CL</given-names>
            </name>
            <name name-style="western">
              <surname>Pulsipher</surname>
              <given-names>KJ</given-names>
            </name>
            <name name-style="western">
              <surname>Harp</surname>
              <given-names>T</given-names>
            </name>
            <name name-style="western">
              <surname>Rundle</surname>
              <given-names>CW</given-names>
            </name>
            <name name-style="western">
              <surname>Sivesind</surname>
              <given-names>TE</given-names>
            </name>
            <name name-style="western">
              <surname>Laughter</surname>
              <given-names>MR</given-names>
            </name>
            <name name-style="western">
              <surname>Dellavalle</surname>
              <given-names>RP</given-names>
            </name>
          </person-group>
          <article-title>Dermatologist influencers on social media: Instagram Reels and TikTok interactive short videos</article-title>
          <source>J Am Acad Dermatol</source>
          <year>2021</year>
          <month>10</month>
          <volume>85</volume>
          <issue>3</issue>
          <fpage>e185</fpage>
          <lpage>e188</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jaad.2021.04.052</pub-id>
          <pub-id pub-id-type="medline">33905784</pub-id>
          <pub-id pub-id-type="pii">S0190-9622(21)00890-2</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref4">
        <label>4</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Aslan Kayıran</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Karadağ</surname>
              <given-names>AS</given-names>
            </name>
            <name name-style="western">
              <surname>Alyamaç</surname>
              <given-names>Gökçen</given-names>
            </name>
            <name name-style="western">
              <surname>Çevirgen Cemil</surname>
              <given-names>Bengü</given-names>
            </name>
            <name name-style="western">
              <surname>Demirseren</surname>
              <given-names>DD</given-names>
            </name>
            <name name-style="western">
              <surname>Aksoy</surname>
              <given-names>H</given-names>
            </name>
            <name name-style="western">
              <surname>Oğuz Kılıç</surname>
              <given-names>Sevilay</given-names>
            </name>
            <name name-style="western">
              <surname>Taş Demircan</surname>
              <given-names>Y</given-names>
            </name>
            <name name-style="western">
              <surname>İnan Yüksel</surname>
              <given-names>Esma</given-names>
            </name>
            <name name-style="western">
              <surname>Kalkan</surname>
              <given-names>G</given-names>
            </name>
            <name name-style="western">
              <surname>Yaşar</surname>
              <given-names>G</given-names>
            </name>
            <name name-style="western">
              <surname>Şikar Aktürk</surname>
              <given-names>Aysun</given-names>
            </name>
            <name name-style="western">
              <surname>Kutlu</surname>
              <given-names>O</given-names>
            </name>
            <name name-style="western">
              <surname>Altıntaş Kakşi</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Elibüyük Aksaç</surname>
              <given-names>Sema</given-names>
            </name>
            <name name-style="western">
              <surname>Kaya Erdoğan</surname>
              <given-names>H</given-names>
            </name>
            <name name-style="western">
              <surname>Kaya Özden</surname>
              <given-names>Hatice</given-names>
            </name>
            <name name-style="western">
              <surname>Sarıkaya Solak</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Koska</surname>
              <given-names>MC</given-names>
            </name>
            <name name-style="western">
              <surname>Yazıcı</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Social media use in patients with acne vulgaris: what do patients expect from social media?</article-title>
          <source>J Cosmet Dermatol</source>
          <year>2021</year>
          <month>08</month>
          <day>18</day>
          <volume>20</volume>
          <issue>8</issue>
          <fpage>2556</fpage>
          <lpage>2564</lpage>
          <pub-id pub-id-type="doi">10.1111/jocd.14272</pub-id>
          <pub-id pub-id-type="medline">34087036</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref5">
        <label>5</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Steeb</surname>
              <given-names>T</given-names>
            </name>
            <name name-style="western">
              <surname>Reinhardt</surname>
              <given-names>L</given-names>
            </name>
            <name name-style="western">
              <surname>Harlaß</surname>
              <given-names>Matthias</given-names>
            </name>
            <name name-style="western">
              <surname>Heppt</surname>
              <given-names>MV</given-names>
            </name>
            <name name-style="western">
              <surname>Meier</surname>
              <given-names>F</given-names>
            </name>
            <name name-style="western">
              <surname>Berking</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Assessment of the quality, understandability, and reliability of YouTube videos as a source of information on basal cell carcinoma: web-based analysis</article-title>
          <source>JMIR Cancer</source>
          <year>2022</year>
          <month>03</month>
          <day>11</day>
          <volume>8</volume>
          <issue>1</issue>
          <fpage>e29581</fpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://cancer.jmir.org/2022/1/e29581/"/>
          </comment>
          <pub-id pub-id-type="doi">10.2196/29581</pub-id>
          <pub-id pub-id-type="medline">35275067</pub-id>
          <pub-id pub-id-type="pii">v8i1e29581</pub-id>
          <pub-id pub-id-type="pmcid">PMC8956995</pub-id>
        </nlm-citation>
      </ref>
    </ref-list>
  </back>
</article>
